Digest Network Come funziona
Network
/
Società
Mi
Non verificato

MindWalk Holdings Corp.

Di cosa scriviamo

BiotecnologiaFarmaceuticaHIV, AIDS e malattie autoimmuniSaluteTecnica

12 comunicati stampa

Guarda tutti i comunicati
14/01/2026
Scienza
Software
Farmaceutica
Salute
HIV, AIDS e malattie autoimmuni
Tecnica
Industria
MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
12/01/2026
Biotecnologia
Tecnica
Associazioni/Professionisti
Salute
Farmaceutica
Scienza
HIV, AIDS e malattie autoimmuni
Software
Industria
REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
10/01/2026
Industria
Biotecnologia
Tecnica
Associazioni/Professionisti
Salute
Farmaceutica
Scienza
HIV, AIDS e malattie autoimmuni
Software
MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
15/12/2025
Web e Social Network
Telefonia e Varie
Mercato azionario
Tecnica
Scienza
HIV, AIDS e malattie autoimmuni
Software
Biotecnologia
Salute
Farmaceutica
MindWalk Reports Record Growth and Announces Strategic Progress on Its AI Asset Pipeline
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
08/12/2025
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Tecnica
Scienza
HIV, AIDS e malattie autoimmuni
Software
Biotecnologia
Salute
Farmaceutica
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2026 on December 15, 2025
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
13/11/2025
Salute
Tecnica
HIV, AIDS e malattie autoimmuni
Farmaceutica
Biotecnologia
Eventi
Fiere
MindWalk CTO Dr. Dirk Van Hyfte to Join Fireside Chat at AI Drug Discovery & Development Summit 2025
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
21/10/2025
Software
Scienza
Farmaceutica
Information Technology
Tecnica
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Biotecnologia
Salute
Mercato del lavoro
MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
15/10/2025
Information Technology
Biotecnologia
Tecnica
Salute
Farmaceutica
Scienza
HIV, AIDS e malattie autoimmuni
Software
Mercato del lavoro
MindWalk Appoints Dr. Thomas W. Lynch as Chief Business Officer to Accelerate Commercial Expansion
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
09/10/2025
Scienza
Biotecnologia
Farmaceutica
Salute
HIV, AIDS e malattie autoimmuni
Tecnica
Finanza
MindWalk Announces Share Repurchase Program
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
22/09/2025
Industria
Software
Scienza
Farmaceutica
Tecnica
HIV, AIDS e malattie autoimmuni
Biotecnologia
Medicina - Varie
Salute
MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0